Literature DB >> 32360563

Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial Survey.

Rachel B Salit1, Stephanie J Lee2, Linda J Burns3, Bronwen E Shaw4, Navneet S Majhail5, Neel S Bhatt2, William A Wood6, Karen L Syrjala2.   

Abstract

Hematopoietic cell transplantation (HCT) requires absence from work, with potential consequences of unemployment and early retirement. Risk factors for failure to return to work (RTW) following HCT have been reported, but there is little information about how transplant centers facilitate the RTW transition for their post-HCT patients. In the present study, we aimed to determine (1) whether transplant centers have guidelines for RTW post-HCT and the consistency of these guidelines and (2) whether centers have RTW programs for their patients, and the characteristics of these programs. We surveyed representatives from 150 adult transplant centers regarding their RTW guidelines and RTW programs. Centers were selected if they performed at least 50 HCTs (autologous [auto] and/or allogeneic [allo]) annually. The online survey contained 32 open-ended and closed-ended questions and 3 questions each eliciting respondents' demographic and transplant centers information. We received completed surveys from 45 centers (30% response rate). Forty-four percent of centers reported having RTW guidelines. All centers recommend RTW at 6 months or less after HCT for their auto-HCT recipients; recommendations for allo-HCT recipients ranged from 4 months to >1 year after HCT having jobs involving interactions with children, sick people, and animals was considered a reason to delay RTW by most centers. Although 87% of centers endorsed that RTW is a problem for post-HCT recipients, only 36% reported having an RTW program for their patients. The majority validated that RTW programs would be either somewhat helpful (36%) or very helpful (51%) for their patients. The majority of responding HCT centers believe that RTW is a problem for patients after HCT; however, consistent guidelines and RTW programs are lacking. With increasing numbers of HCT survivors, efforts to create standardized guidelines and to develop RTW programs are needed.
Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Guidelines; Return to work; Support programs; Survivorship

Mesh:

Year:  2020        PMID: 32360563      PMCID: PMC7546432          DOI: 10.1016/j.bbmt.2020.04.022

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  22 in total

Review 1.  A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology.

Authors:  Martin Fortin; Moira Stewart; Marie-Eve Poitras; José Almirall; Heather Maddocks
Journal:  Ann Fam Med       Date:  2012 Mar-Apr       Impact factor: 5.166

2.  A qualitative study of work and work return in cancer survivors.

Authors:  Deborah S Main; Carolyn T Nowels; Tia A Cavender; Martine Etschmaier; John F Steiner
Journal:  Psychooncology       Date:  2005-11       Impact factor: 3.894

Review 3.  Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work.

Authors:  Mary Stergiou-Kita; Alisa Grigorovich; Victrine Tseung; Elizabeth Milosevic; Debbie Hebert; Stephanie Phan; Jennifer Jones
Journal:  J Cancer Surviv       Date:  2014-07-04       Impact factor: 4.442

4.  Returning to work after treatment for haematological cancer: findings from Australia.

Authors:  Pam D McGrath; Barbara Hartigan; Hamish Holewa; Maryanne Skarparis
Journal:  Support Care Cancer       Date:  2011-10-28       Impact factor: 3.603

Review 5.  Patient-centered care coordination in hematopoietic cell transplantation.

Authors:  Nandita Khera; Patricia Martin; Kristen Edsall; Anthony Bonagura; Linda J Burns; Mark Juckett; Olivia King; C Frederick LeMaistre; Navneet S Majhail
Journal:  Blood Adv       Date:  2017-08-22

6.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  Navneet S Majhail; J Douglas Rizzo; Stephanie J Lee; Mahmoud Aljurf; Yoshiko Atsuta; Carmem Bonfim; Linda J Burns; Naeem Chaudhri; Stella Davies; Shinichiro Okamoto; Adriana Seber; Gerard Socie; Jeff Szer; Maria Teresa Van Lint; John R Wingard; Andre Tichelli
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-13       Impact factor: 5.742

7.  Cancer survivors' experiences of return to work: A qualitative study.

Authors:  Vahid Zamanzadeh; Leila Valizadeh; Azad Rahmani; Mohammad Zirak; Huget Desiron
Journal:  Psychooncology       Date:  2018-08-07       Impact factor: 3.894

8.  Enhancing return-to-work in cancer patients, development of an intervention and design of a randomised controlled trial.

Authors:  Sietske J Tamminga; Angela G E M de Boer; Jos H A M Verbeek; Taina Taskila; Monique H W Frings-Dresen
Journal:  BMC Cancer       Date:  2010-07-01       Impact factor: 4.430

9.  Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation.

Authors:  Anne C Kirchhoff; Wendy Leisenring; Karen L Syrjala
Journal:  J Cancer Surviv       Date:  2010-03       Impact factor: 4.442

10.  Effectiveness of a hospital-based work support intervention for female cancer patients - a multi-centre randomised controlled trial.

Authors:  Sietske J Tamminga; Jos H A M Verbeek; Monique M E M Bos; Guus Fons; Jos J E M Kitzen; Peter W Plaisier; Monique H W Frings-Dresen; Angela G E M de Boer
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more
  1 in total

1.  Psychosocial and financial issues after hematopoietic cell transplantation.

Authors:  David Buchbinder; Nandita Khera
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.